Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead-in phase of a randomised controlled trial
PsiquiatriaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Journal of child psychology and psychiatry, and allied disciplines
- Publicado em
- 19 jan 2026
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead-in phase of a randomised controlled trial
Kelsie A Boulton, Rinku Thapa, Yun Ju Song, Andrew J O Whitehouse, Marilena M DeMayo, Simon G Gregory, Izabella Pokorski, Joanna Granich, Zahava Ambarchi, John Wray et al.
Descritores MeSH
- Autism Spectrum Disorder
- Autistic Disorder
- Oxytocin
- Placebo Effect
- Outcome Assessment, Health Care
- Double-Blind Method
- Female
- Humans
- Male
- Administration, Intranasal
Veja também
Estudos relacionados
- The neural effects of oxytocin administration in autism spectrum disorders studied by fMRI: A systematic review
- Predictors of Placebo Response in the Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors
- The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial
- Chronic oxytocin administration stimulates the oxytocinergic system in children with autism